QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (44) Citing Articles via Google Scholar Google Scholar Articles by Xu, J. Articles by Hsu, C. Y. Search for Related Content PubMed PubMed Citation Articles by Xu, J. Articles by Hsu, C. Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB METHYLPREDNISOLONE RU-486 Medline Plus Health Information Spinal Cord Injuries

 Previous Article  |  Next Article 

The Journal of Neuroscience, January 1, 2001, 21(1):92-97

Glucocorticoid Receptor-Mediated Suppression of Activator Protein-1 Activation and Matrix Metalloproteinase Expression after Spinal Cord Injury

Jan Xu¹, Gyeong-Moon Kim¹, S. Hinan Ahmed¹, Jinming Xu¹, Ping Yan², Xiao Ming Xu², and Chung Y. Hsu¹

¹ Department of Neurology and Center for the Study of Nervous System Injury, Washington University School of Medicine, St. Louis, Missouri 63110, and ² Department of Anatomy and Neurobiology, Saint Louis University School of Medicine, St. Louis, Missouri 63104

Post-traumatic inflammatory reaction may contribute to progressive tissue damage after spinal cord injury (SCI). Two key transcription factors, nuclear factor B (NF-B) and activator protein-1 (AP-1), are activated in inflammation. An increase in NF-B binding activity has been shown in the injured spinal cord. We report activation of AP-1 after SCI. Electrophoretic mobility shift assay showed that AP-1 binding activity increased after SCI, starting at 1 hr, peaking at 8 hr, and declining to basal levels by 7 d. Methylprednisolone (MP) is the only therapeutic agent approved by the Food and Drug Administration for treating patients with acute traumatic SCI. MP reduced post-traumatic AP-1 activation. RU486, a glucocorticoid receptor (GR) antagonist, reversed MP inhibition of AP-1 activation. Immunostaining showed an increase in the expression of the Fos-B and c-Jun components of AP-1 in the injured cord. A c-fos antisense oligodeoxynucleotide (ODN) inhibited AP-1, but not NF-B, activation after SCI. AP-1 and NF-B can transactivate genes encoding matrix metalloproteinase-1 (MMP-1) and MMP-9. Western blotting and immunostaining show increased expression of MMP-1 and MMP-9 in the injured cord. MP inhibited MMP-1 and MMP-9 expression after SCI. RU486 reversed this MP effect. The c-fos antisense ODN, however, failed to suppress MMP-1 or MMP-9 expression. These findings demonstrate that MP may suppress post-traumatic inflammatory reaction by inhibiting both the AP-1 and NF-B transcription cascades via a GR mechanism. Expression of inflammatory genes such as MMP-1 and MMP-9 that are transactivated jointly by AP-1 and NF-B may not be suppressed by inhibiting only AP-1 activity.

Key words: inflammation; methylprednisolone; NF-B; protease; RU486; transcription factor

---

Copyright © 2001 Society for Neuroscience  0270-6474/01/21192-06$05.00/0

This article has been cited by other articles:

				S. A. Busch, K. P. Horn, D. J. Silver, and J. Silver Overcoming Macrophage-Mediated Axonal Dieback Following CNS Injury J. Neurosci., August 12, 2009; 29(32): 9967 - 9976. [Abstract] [Full Text] [PDF]

				J. Xu, S. Chen, H. Chen, Q. Xiao, C. Y. Hsu, D. Michael, and J. Bao STAT5 Mediates Antiapoptotic Effects of Methylprednisolone on Oligodendrocytes J. Neurosci., February 18, 2009; 29(7): 2022 - 2026. [Abstract] [Full Text] [PDF]

				T. Y. Yune, J. Y. Lee, G. Y. Jung, S. J. Kim, M. H. Jiang, Y. C. Kim, Y. J. Oh, G. J. Markelonis, and T. H. Oh Minocycline Alleviates Death of Oligodendrocytes by Inhibiting Pro-Nerve Growth Factor Production in Microglia after Spinal Cord Injury J. Neurosci., July 18, 2007; 27(29): 7751 - 7761. [Abstract] [Full Text] [PDF]

				J S Sloka and M Stefanelli The mechanism of action of methylprednisolone in the treatment of multiple sclerosis Multiple Sclerosis, August 1, 2005; 11(4): 425 - 432. [Abstract] [PDF]

				A. C. Hansson, W. Sommer, R. Rimondini, B. Andbjer, I. Stromberg, and K. Fuxe c-fos Reduces Corticosterone-Mediated Effects on Neurotrophic Factor Expression in the Rat Hippocampal CA1 Region J. Neurosci., July 9, 2003; 23(14): 6013 - 6022. [Abstract] [Full Text] [PDF]

				K. J. Yin, J.-M. Lee, S. D. Chen, J. Xu, and C. Y. Hsu Amyloid-beta Induces Smac Release via AP-1/Bim Activation in Cerebral Endothelial Cells J. Neurosci., November 15, 2002; 22(22): 9764 - 9770. [Abstract] [Full Text] [PDF]

				L. J. Noble, F. Donovan, T. Igarashi, S. Goussev, and Z. Werb Matrix Metalloproteinases Limit Functional Recovery after Spinal Cord Injury by Modulation of Early Vascular Events J. Neurosci., September 1, 2002; 22(17): 7526 - 7535. [Abstract] [Full Text] [PDF]

				G.-M. Kim, J. Xu, J. Xu, S.-K. Song, P. Yan, G. Ku, X. M. Xu, and C. Y. Hsu Tumor Necrosis Factor Receptor Deletion Reduces Nuclear Factor-{kappa}B Activation, Cellular Inhibitor of Apoptosis Protein 2 Expression, and Functional Recovery after Traumatic Spinal Cord Injury J. Neurosci., September 1, 2001; 21(17): 6617 - 6625. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help